Yersinia pestis lineages in Mongolia.

PloS One
Julia M RiehmHolger C Scholz

Abstract

Whole genome sequencing allowed the development of a number of high resolution sequence based typing tools for Yersinia (Y.) pestis. The application of these methods on isolates from most known foci worldwide and in particular from China and the Former Soviet Union has dramatically improved our understanding of the population structure of this species. In the current view, Y. pestis including the non or moderate human pathogen Y. pestis subspecies microtus emerged from Yersinia pseudotuberculosis about 2,600 to 28,600 years ago in central Asia. The majority of central Asia natural foci have been investigated. However these investigations included only few strains from Mongolia. Clustered Regularly Interspaced Short Prokaryotic Repeats (CRISPR) analysis and Multiple-locus variable number of tandem repeats (VNTR) analysis (MLVA) with 25 loci was performed on 100 Y. pestis strains, isolated from 37 sampling areas in Mongolia. The resulting data were compared with previously published data from more than 500 plague strains, 130 of which had also been previously genotyped by single nucleotide polymorphism (SNP) analysis. The comparison revealed six main clusters including the three microtus biovars Ulegeica, Altaica, and Xilingolens...Continue Reading

References

Aug 30, 2001·Journal of Clinical Microbiology·A M KlevytskaP Keim
Jul 16, 2003·Drugs of Today·Philip Sambrook
Apr 16, 2004·Clinical Microbiology Reviews·Andrey P AnisimovGerald B Pier
Jun 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jessica M GirardPaul Keim
Sep 29, 2004·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Paul KeimDavid M Wagner
Dec 16, 2004·Proceedings of the National Academy of Sciences of the United States of America·Mark AchtmanPaul Keim
Nov 10, 2006·Journal of Clinical Microbiology·Matthew N Van ErtPaul Keim
Jun 1, 2007·Nucleic Acids Research·Ibtissem GrissaChristine Pourcel
Apr 30, 2008·Nucleic Acids Research·Ibtissem GrissaChristine Pourcel
May 19, 2009·Antonie van Leeuwenhoek·Joseph J KingstonHarsh V Batra
Jun 13, 2009·Methods in Molecular Biology·Ibtissem GrissaChristine Pourcel
Feb 18, 2010·Vector Borne and Zoonotic Diseases·Bolormaa GaldanOtgonbaatar Dashdavaa
Oct 12, 2010·Molecular and Cellular Probes·Julia M RiehmHerbert Tomaso
Oct 16, 2010·PLoS Pathogens·Stephanie HaenschBarbara Bramanti
Nov 3, 2010·Nature Genetics·Giovanna MorelliMark Achtman
Aug 31, 2011·Proceedings of the National Academy of Sciences of the United States of America·Verena J SchuenemannHendrik N Poinar
Sep 21, 2011·PLoS Neglected Tropical Diseases·Amy J VoglerPaul Keim
Oct 14, 2011·Nature·Kirsten I BosJohannes Krause

❮ Previous
Next ❯

Citations

Apr 13, 2013·Genome Announcements·Mikhail E PlatonovAndrey P Anisimov
Jan 19, 2016·Diagnostic Microbiology and Infectious Disease·Luke C KingryJeannine M Petersen
Jan 17, 2016·Annual Review of Food Science and Technology·Rodolphe Barrangou, Edward G Dudley
Nov 1, 2015·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Amy J VoglerDavid M Wagner
Dec 7, 2014·Microbiology·Nikki ShariatEdward G Dudley
Aug 30, 2012·Expert Opinion on Biological Therapy·Marja-Leena LähdeahoMarkku Mäki
May 13, 2015·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Julia M Riehm, Thomas Löscher
May 13, 2015·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Yolande HauckChristine Pourcel
Dec 23, 2014·Emerging Infectious Diseases·Vincent RichardMinoarisoa Rajerison
Sep 30, 2014·PloS One·Maria Paloma S BarrosTereza Cristina Leal-Balbino
Aug 19, 2016·Proceedings. Biological Sciences·Mark Achtman
Jun 14, 2018·PloS One·Liyuan ShiPeng Wang
Oct 29, 2013·Applied and Environmental Microbiology·Nikki Shariat, Edward G Dudley
Mar 7, 2014·Microbiology and Molecular Biology Reviews : MMBR·Rogier LouwenJohn van der Oost
Jan 13, 2018·Pathogens and Disease·Liliana Medina-AparicioIsmael Hernández-Lucas
Nov 22, 2013·Biochemical Society Transactions·Whitney E England, Rachel J Whitaker
Jun 13, 2015·PLoS Neglected Tropical Diseases·Julia M RiehmHolger C Scholz
Apr 3, 2018·PeerJ·Olga O BochkarevaMikhail S Gelfand
Jan 1, 2017·Biologie aujourd'hui·Christine Pourcel
May 30, 2019·Proceedings of the National Academy of Sciences of the United States of America·Lei XuZhibin Zhang
Dec 11, 2020·Clinical Microbiology Reviews·R BarbieriM Drancourt
Feb 1, 2015·Microbiology·Nikki ShariatEdward G Dudley

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
electrophoresis

Software Mentioned

MLVA25
CRISPRcompar
BioNumerics
MLVA

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.